Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SERYNOX 50% /50% GAS COMPRIMIDO MEDICINAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/SERYNOX 50% /50% GAS COMPRIMIDO MEDICINAL

Approved

STANDARD

SERYNOX 50% /50% GAS COMPRIMIDO MEDICINAL

Messer Iberica De Gases, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 25, 2021
Approval ID: da7dca4dda33d9cb
Company: Messer Iberica De Gases, S.A.U.
Type: Standard

Approval Details

Approval Id: da7dca4dda33d9cb
Drug Cima Aemps Name: SERYNOX 50% /50% GAS COMPRIMIDO MEDICINAL
Register Number: 85871
Holder Company Name: Messer Iberica De Gases, S.A.U.
Marketing Company Name: Messer Iberica De Gases, S.A.U.
Authorization Date: 2021-03-25
Dosage Form: GAS COMPRIMIDO MEDICINAL
Dose: 50 / 50 % (V/V)
Route Of Administration: VÍA INHALATORIA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Messer Iberica De Gases, S.A.U.

Active Ingredients

OXIDO NITROSO

50 % V/V

OXIGENO

50 % V/V

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 25, 2021

Approval ID

da7dca4dda33d9cb

Type

Standard

Back to CIMA-AEMPS Approvals